Related Experiment Videos
[Chest pain and sulprostone during postpartum hemorrhage]
F Bayoumeu1, M Aallali, A Koebele
1Service d'anesthésie-réanimation, maternité régionale, 10, rue du Dr Heydenreich, 54042 Nancy, France. secretariat.anesthesie@maternite.chu-nancy-fr
Annales Francaises D'Anesthesie Et De Reanimation
|December 11, 2002
Summary
A woman experienced chest pain after sulprostone administration post-vaginal delivery. The chest pain resolved upon stopping sulprostone, suggesting a potential link to coronary artery spasm.
Area of Science:
- Obstetrics and Gynecology
- Cardiology
- Pharmacology
Background:
- Postpartum care often involves medications to manage complications.
- Sulprostone is a prostaglandin analog used in obstetrics.
- Epidural analgesia is common during labor and delivery.
Observation:
- A 31-year-old woman developed chest pain shortly after sulprostone administration following vaginal delivery.
- The chest pain resolved completely upon discontinuation of sulprostone.
- Ischemia-related tests and coronary angiography were normal.
Findings:
- The clinical presentation suggests sulprostone-induced coronary artery spasm.
- Pharmacological review indicates sulprostone's potential effects on coronary circulation.
- Comparison with existing literature supports the possibility of vasospastic events.
Implications:
- Clinicians should be aware of the potential cardiac side effects of sulprostone.
- Careful patient selection and monitoring are recommended before and during sulprostone use.
- This case highlights the importance of considering coronary artery spasm in patients presenting with chest pain during sulprostone therapy.